The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT05453513
- Status
- Recruiting
Conditions
- Cannabis Use Disorder
- Depression
- HIV
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 59 Years
- Healthy Volunteers
- Not accepted
Interventions
- MRI Study — BEHAVIORALfMRI Tasks
Study Details
To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study team proposes a tightly integrative study to test the overall hypothesis that cannabis use and depression in young PLWH have an additive effect, inducing both reward deficits and pain hypersensitivity, and that this pattern will predict worse outcomes at 1 year follow-up.
Key Dates
- Start date
- Apr 1, 2022
- Status verified
- May 2025
- Primary completion
- Jul 30, 2027
- Completion
- Jul 30, 2027
Study Design
- Enrollment
- 280 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Neural Underpinnings of Depression GroupAll participants will undergo neuroimaging and behavioral tests. during the course of the study (12 months).
Primary Outcome Measure
Addiction Severity Index (ASI) [ Time Frame: Up to 1 year ]
Central Contacts
- Vilma Gabbay, MD305-243-2382
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Joanna Starrels, MD (SUB_INVESTIGATOR) Anjali Sharma, MD (SUB_INVESTIGATOR) Vilma Gabbay, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By research site
Related Studies
- Lay-Delivered Behavioral Activation in Senior CentersRecruiting · University of Washington · Brandon, Florida
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)Recruiting · Florida International University · Coral Gables, Florida
- Transdiagnostic Intervention to Reduce Internalized Health-Related StigmaRecruiting · University of Florida · Gainesville, Florida